Travaux scientifiques

Prof. Dr. Doğan Uncu

218 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Prognostic Significance of HER2 Positivity in Endometrium Cancer

    Oncology Research and Treatment, 2024

    DOI 10.1159/000542900 PMID 39616989 2 citations (OpenAlex) Source : OpenAlex

  2. Clinical features and prognostic factors in thymoma and thymic carcinoma

    Indian Journal of Thoracic and Cardiovascular Surgery, 2024

    DOI 10.1007/s12055-024-01741-6 PMID 39416339 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  3. Cabozantinib-induced heart failure

    Journal of Oncology Pharmacy Practice, 2024

    DOI 10.1177/10781552231203703 PMID 37817663 2 citations (Europe PMC) Source : ORCID

  4. Comparison of Different Machine Learning Models for Predicting Long-Term Overall Survival in Non-metastatic Colorectal Cancers

    Cureus, 2024

    DOI 10.7759/cureus.75713 PMID 39811215 14 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  5. A rare EGFR exon 19 insertion mutation in metastatic lung adenocarcinoma: a favorable response to afatinib

    Anti-Cancer Drugs, 2024

    DOI 10.1097/cad.0000000000001671 PMID 39749551 Source : OpenAlex

  6. Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving Chemoimmunotherapy

    Expert Opinion on Pharmacotherapy, 2024

    DOI 10.1080/14656566.2024.2391007 PMID 39115275 4 citations (Europe PMC) Source : ORCID

  7. Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study

    Clinical and Translational Oncology, 2024

    DOI 10.1007/s12094-024-03410-x PMID 38451412 Source : ORCID

  8. 46P The frequency of driver mutations in non-small cell cancer patients: Analysis of the 5064 patients in the Turkish nation-wide, observational, registurkLung study

    ESMO Open, 2024

    DOI 10.1016/j.esmoop.2024.102625 Texte intégral en libre accèsSource : OpenAlex

  9. Primary colon lymphomas: An analysis of our experience over the last 18 years

    Medicine, 2024

    DOI 10.1097/md.0000000000038013 PMID 38728507 5 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  10. Clinicopathological features and treatment outcomes of urothelial carcinoma variant histologies and non-urothelial bladder cancers

    International Urology and Nephrology, 2024

    DOI 10.1007/s11255-024-04341-w PMID 39729262 5 citations (OpenAlex) Source : OpenAlex

  11. Is fibroblast growth factor 11 (FGF11) a predictive marker for breast cancer?

    Medicine, 2024

    DOI 10.1097/md.0000000000037656 PMID 38552037 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  12. How illness perception congruence between patients with cancer and caregivers affects their anxiety and depression levels

    Journal of Psychosocial Oncology Research and Practice, 2024

    DOI 10.1097/or9.0000000000000145 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  13. Sensitivity of frozen section analysis in patients with ovarian adult granulosa cell tumor, a multi-center study

    Archives of Gynecology and Obstetrics, 2024

    DOI 10.1007/s00404-024-07710-z PMID 39214901 1 citation (OpenAlex) Source : OpenAlex

  14. Management and prognosis of patients with cancer of unknown primary: 20 years of experience

    Turkish journal of medical sciences, 2023

    DOI 10.55730/1300-0144.5741 PMID 38813492 2 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  15. Neoadjuvant Chemotherapy Followed by Cytoreductive Surgery and HIPEC Improves Survival in Peritoneal Metastatic Gastric Cancer

    Oncology, 2023

    DOI 10.1159/000528609 PMID 36809752 11 citations (OpenAlex) Source : OpenAlex

  16. Evaluation of clinical and prognostic factors for primary gastric diffuse large B-cell lymphoma: Single-center experience

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_2111_21 PMID 37470610 6 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  17. Is adjuvant chemotherapy necessary for 2014 FIGO stage IC adult granulosa cell tumor?: Multicentric Turkish study

    Asia-Pacific Journal of Clinical Oncology, 2023

    DOI 10.1111/ajco.13942 PMID 37096294 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  18. A multicentre, multinational study of clinical characteristics and prognosis of hepatocellular carcinoma

    Eastern Mediterranean Health Journal, 2023

    DOI 10.26719/emhj.23.087 PMID 37551758 5 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  19. Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer

    African Journal of Urology, 2023

    DOI 10.1186/s12301-023-00398-8 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  20. The Prognostic and Functional Impact of Sprouty 2 Expression in Non–small Cell Lung Cancer

    American Journal of Clinical Oncology, 2023

    DOI 10.1097/coc.0000000000001044 PMID 37700432 Source : OpenAlex

  21. #356 Sensitivity of frozen section analysis in patients with ovarian adult granulosa cell tumor, a multi-center study

    International Journal of Gynecological Cancer, 2023

    DOI 10.1136/ijgc-2023-esgo.564 Texte intégral en libre accèsSource : OpenAlex

  22. Is the watch‐and‐wait strategy suitable for every patient who has achieved a complete clinical response with neoadjuvant treatment in locally advanced rectum cancer?

    Journal of Surgical Oncology, 2023

    DOI 10.1002/jso.27537 PMID 38031877 Texte intégral en libre accèsSource : OpenAlex

  23. First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal carcinoma

    Bosnian Journal of Basic Medical Sciences, 2022

    DOI 10.17305/bjbms.2021.7069 PMID 35460397 4 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  24. The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients

    Pancreas, 2022

    DOI 10.1097/mpa.0000000000002167 PMID 37078939 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  25. Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer

    Journal of Cancer Research and Therapeutics, 2022

    DOI 10.4103/jcrt.jcrt_1104_21 PMID 36510987 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  26. Clinicopathologİcal Features and Survival Outcomes of 70 Tongue Squamous Cell Carcinoma Patients

    Acta Oncologica Turcica, 2022

    DOI 10.5505/aot.2022.59002 Texte intégral en libre accèsSource : OpenAlex

  27. 120P Efficacy of postoperative radiotherapy (PORT) in stage IIIA-N2 non-small cell lung cancer: Meta-analysis of randomized controlled studies

    Annals of Oncology, 2022

    DOI 10.1016/j.annonc.2022.02.147 Texte intégral en libre accèsSource : OpenAlex

  28. The prognostic value of Sprouty2 protein in nonsmall cell lung cancer.

    Journal of Clinical Oncology, 2022

    DOI 10.1200/jco.2022.40.16_suppl.e20524 Source : OpenAlex

  29. Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group

    Journal of Gastrointestinal Cancer, 2021

    DOI 10.1007/s12029-021-00594-1 PMID 33538958 4 citations (Europe PMC) Source : OpenAlex

  30. Thirty-day mortality rates after immunotherapy initiation

    Immunotherapy, 2021

    DOI 10.2217/imt-2021-0082 PMID 34676791 2 citations (Europe PMC) Source : Europe PMC

  31. Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy

    Future oncology (London, England), 2021

    DOI 10.2217/fon-2021-0597 PMID 34342517 28 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  32. The effect of chemotherapy on olfactory function and mucociliary clearance

    Supportive Care in Cancer, 2021

    DOI 10.1007/s00520-020-05639-y PMID 32749656 6 citations (Europe PMC) Source : ORCID

  33. Baseline 18F-FDG PET textural features as predictors of response to chemotherapy in diffuse large B-cell lymphoma

    Nuclear Medicine Communications, 2021

    DOI 10.1097/mnm.0000000000001447 PMID 34075009 20 citations (Europe PMC) Source : ORCID

  34. A Comparison of Osseous and Extraosseous Ewing Sarcoma

    Journal of College of Physicians And Surgeons Pakistan, 2021

    DOI 10.29271/jcpsp.2021.01.27 PMID 33546529 4 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  35. An Overview of Seminomatous and Non-Seminomatous Germ Cell Testicular Tumors: A Single-center Experience

    Bulletin of Urooncology, 2021

    DOI 10.4274/uob.galenos.2021.2021.3.1 Texte intégral en libre accèsSource : OpenAlex

  36. Does Prognostic Nutritional Index Predict Survival in Operated Papilla Vateri Tumors? A Single-centre Experience

    Journal of College of Physicians and Surgeons Pakistan, 2021

    DOI 10.29271/jcpsp.2021.12.1428 PMID 34794282 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

  37. The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study

    International Journal of Colorectal Disease, 2021

    DOI 10.1007/s00384-021-03888-9 PMID 33586012 28 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  38. 976P The 30-day mortality rate after first cycle of immunotherapy

    Annals of Oncology, 2021

    DOI 10.1016/j.annonc.2021.08.1360 Texte intégral en libre accèsSource : OpenAlex

  39. The Relationship Between Plexin C1 Overexpression and Survival in Hepatocellular Carcinoma: a Turkish Oncology Group (TOG) Study

    Journal of Gastrointestinal Cancer, 2021

    DOI 10.1007/s12029-021-00602-4 PMID 33656690 5 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  40. The Comparison of mDCF and mFOLFOX-6 as First-Line Treatment in Metastatic Gastric Cancer

    Cureus, 2021

    DOI 10.7759/cureus.14882 PMID 34104608 5 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  41. Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data.

    PubMed, 2021

    PMID 34564997 4 citations (OpenAlex) Source : OpenAlex

  42. Is the nuclear factor kappa-b (NF-κB) pathway and inflammatory status associated with colorectal cancer?

    Saudi Journal of Gastroenterology, 2021

    DOI 10.4103/sjg.sjg_44_21 PMID 34380870 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  43. 570P Retrospective analysis of PDL-1, LAG3, TIM3, OX40L and MSI status in gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

    Annals of Oncology, 2021

    DOI 10.1016/j.annonc.2021.08.705 Texte intégral en libre accèsSource : OpenAlex

  44. 1226P Efficacy and safety of Anti-EGFR TKIs combined with bevacizumab or ramucirumab in the first-line treatment of non-small cell lung cancer: Meta-analysis of randomized controlled trials

    Annals of Oncology, 2021

    DOI 10.1016/j.annonc.2021.08.1831 Texte intégral en libre accèsSource : OpenAlex

  45. Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer

    Tumori Journal, 2020

    DOI 10.1177/0300891620969823 PMID 33167790 4 citations (Europe PMC) Source : OpenAlex

  46. PROGNOSTIC AND PREDICTIVE MARKERS OF FOLFIRI/AFLIBERCEPT IN PATIENTS WITH METASTATIC COLORECTAL CANCER (TOG STUDY)

    AYBU AVESIS, 2020

    Source : OpenAlex

  47. Third-line Therapy for Metastatic Renal Cell Carcinoma and Its Effect on Quality of Life and Overall Survival: A National, Multicenter, Observational Study

    Journal of Oncological Sciences, 2020

    DOI 10.37047/jos.2020-75080 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  48. The prognostic value of the prognostic nutritional index in patients with metastatic colorectal cancer

    Asia-Pacific journal of clinical oncology, 2020

    DOI 10.1111/ajco.13328 PMID 32301263 16 citations (Europe PMC) Source : Europe PMC

  49. The Negative RT-PCR Test is Enough to Rule Out Covıd-19 in Cancer Patients or Not? Covıd-19 or Not?

    Journal of Biomedical Research & Environmental Sciences, 2020

    DOI 10.37871/jbres1141 Source : OpenAlex

  50. Clinical features and prognostic factors in small bowel tumors: A retrospective evaluation of eighty cases

    Annals of Medical Research, 2020

    DOI 10.5455/annalsmedres.2019.09.553 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex